Cargando…

Two-pore channels and disease()

Two-pore channels (TPCs) are Ca(2+)-permeable endo-lysosomal ion channels subject to multi-modal regulation. They mediate their physiological effects through releasing Ca(2+) from acidic organelles in response to cues such as the second messenger, NAADP. Here, we review emerging evidence linking TPC...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Sandip, Kilpatrick, Bethan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Pub. Co 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162333/
https://www.ncbi.nlm.nih.gov/pubmed/29746898
http://dx.doi.org/10.1016/j.bbamcr.2018.05.004
_version_ 1783359122084724736
author Patel, Sandip
Kilpatrick, Bethan S.
author_facet Patel, Sandip
Kilpatrick, Bethan S.
author_sort Patel, Sandip
collection PubMed
description Two-pore channels (TPCs) are Ca(2+)-permeable endo-lysosomal ion channels subject to multi-modal regulation. They mediate their physiological effects through releasing Ca(2+) from acidic organelles in response to cues such as the second messenger, NAADP. Here, we review emerging evidence linking TPCs to disease. We discuss how perturbing both local and global Ca(2+) changes mediated by TPCs through chemical and/or molecular manipulations can induce or reverse disease phenotypes. We cover evidence from models of Parkinson's disease, non-alcoholic fatty liver disease, Ebola infection, cancer, cardiac dysfunction and diabetes. A need for more drugs targeting TPCs is identified.
format Online
Article
Text
id pubmed-6162333
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier Pub. Co
record_format MEDLINE/PubMed
spelling pubmed-61623332018-11-01 Two-pore channels and disease() Patel, Sandip Kilpatrick, Bethan S. Biochim Biophys Acta Article Two-pore channels (TPCs) are Ca(2+)-permeable endo-lysosomal ion channels subject to multi-modal regulation. They mediate their physiological effects through releasing Ca(2+) from acidic organelles in response to cues such as the second messenger, NAADP. Here, we review emerging evidence linking TPCs to disease. We discuss how perturbing both local and global Ca(2+) changes mediated by TPCs through chemical and/or molecular manipulations can induce or reverse disease phenotypes. We cover evidence from models of Parkinson's disease, non-alcoholic fatty liver disease, Ebola infection, cancer, cardiac dysfunction and diabetes. A need for more drugs targeting TPCs is identified. Elsevier Pub. Co 2018-11 /pmc/articles/PMC6162333/ /pubmed/29746898 http://dx.doi.org/10.1016/j.bbamcr.2018.05.004 Text en © 2018 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Patel, Sandip
Kilpatrick, Bethan S.
Two-pore channels and disease()
title Two-pore channels and disease()
title_full Two-pore channels and disease()
title_fullStr Two-pore channels and disease()
title_full_unstemmed Two-pore channels and disease()
title_short Two-pore channels and disease()
title_sort two-pore channels and disease()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162333/
https://www.ncbi.nlm.nih.gov/pubmed/29746898
http://dx.doi.org/10.1016/j.bbamcr.2018.05.004
work_keys_str_mv AT patelsandip twoporechannelsanddisease
AT kilpatrickbethans twoporechannelsanddisease